What are the marketed Anticoagulant drugs?

Marketed Anticoagulant drugs include full amount low molecular weight heparin, Traditional anticoagulation, Heparin Sodium In Plastic Container, Heparin Sodium In Plastic Container, Low-dose heparin, Heparin sodium lock solution.

Anticoagulant

27 marketed 15 in Phase 3 3 in Phase 2

This page covers all Anticoagulant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Antithrombin III (enhancer); Factor Xa and Factor IIa (indirect targets), Vitamin K-dependent coagulation factors (II, VII, IX, X) or thrombin/Factor Xa, Antithrombin III, Coagulation Factors Xa and IIa.

Targets

Antithrombin III (enhancer); Factor Xa and Factor IIa (indirect targets) · Vitamin K-dependent coagulation factors (II, VII, IX, X) or thrombin/Factor Xa · Antithrombin III, Coagulation Factors Xa and IIa · Antithrombin III; Coagulation Factors Xa and IIa · Antithrombin III (indirect target); Thrombin (Factor IIa) and Factor Xa (downstream targets) · Antithrombin III (indirect target); Thrombin and Factor Xa (downstream targets) · Antithrombin III (indirect); Thrombin and Factor Xa (downstream targets) · Antithrombin III (enhancer); Thrombin (Factor IIa) and Factor Xa (indirect inhibition) · Ionized calcium (Ca2+) · Antithrombin III (indirect); Factor Xa and Factor IIa

Marketed (27)

full amount low molecular weight heparin · Beijing Anzhen Hospital · Cardiovascular
Low molecular weight heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates clotting factors Xa and IIa.
Traditional anticoagulation · University of Sao Paulo General Hospital · Cardiovascular
Traditional anticoagulation prevents blood clot formation by inhibiting coagulation cascade factors, typically through vitamin K antagonism or direct thrombin/factor Xa inhibition.
Heparin Sodium In Plastic Container · Fresenius Kabi · Cardiovascular
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Low-dose heparin · San Filippo Neri General Hospital · Cardiovascular
Low-dose heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates clotting factors IIa and Xa.
Heparin sodium lock solution · Hospital Civil de Guadalajara · Cardiovascular / Thromboembolism Prevention
Heparin sodium inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors.
Heparin administration · Anemia Working Group Romania · Cardiovascular
Heparin is an anticoagulant that inhibits blood clotting by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Standard Dose of Unfractionated Heparin · University of California, Los Angeles · Cardiovascular
Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Trissodium Citrate 30% · University of Sao Paulo · Hematology
Trisodium citrate acts as an anticoagulant by chelating calcium ions, thereby inhibiting the coagulation cascade and preventing blood clot formation.
low molecule heparin · Second Affiliated Hospital, School of Medicine, Zhejiang University · Cardiovascular
Low molecular weight heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates clotting factors Xa and IIa.
prophylactic heparin · Matthew Neal MD · Cardiovascular
Prophylactic heparin inhibits blood clotting by enhancing the activity of antithrombin III, preventing thrombus formation.
Standard heparin dose · University of Utah · Cardiovascular
Standard heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Continuation of oral anticoagulants · St. Antonius Hospital · Cardiovascular
Oral anticoagulants prevent blood clot formation by inhibiting coagulation cascade factors, reducing thromboembolism risk.
Anticoagulation with heparin · Boston Scientific Corporation · Cardiovascular
Heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
High dose of Unfractionated Heparin · University of Patras · Cardiovascular
High-dose unfractionated heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors.
Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Standard dose heparin · San Filippo Neri General Hospital · Cardiovascular
Heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Heparin fixed doses · SANE-Society of Anesthesiology · Cardiovascular
Heparin is an anticoagulant that inhibits blood clotting by potentiating antithrombin III, which inactivates thrombin and other clotting factors.
Heparin Sodium In Plastic Container · Fresenius Kabi
Heparin enhances Antithrombin III activity to inhibit coagulation factors Xa and IIa.
Heparin anticoagulation · University Medical Centre Ljubljana · Cardiovascular
Heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Unfractionated heparin(UFH) · Beijing Chao Yang Hospital · Cardiovascular
Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Un-fractionated heparin · Deutsches Herzzentrum Muenchen · Cardiovascular
Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Heparin or Bivalirudin · CCRF Consulting Co., Ltd. · Cardiovascular
Heparin and bivalirudin are anticoagulants that prevent blood clot formation by inhibiting thrombin and other coagulation factors.
Anticoagulant Therapy · Shenyang Northern Hospital · Cardiovascular
Anticoagulant therapy prevents blood clot formation by inhibiting coagulation cascade factors or platelet aggregation.
Unfractionated Heparin IV · The TIMI Study Group · Cardiovascular
Unfractionated heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Standard anticoagulation · Faculty Hospital Kralovske Vinohrady · Cardiovascular
Standard anticoagulation prevents blood clot formation by inhibiting coagulation cascade factors, reducing thrombotic events.
No low molecular weight heparin · Beijing Anzhen Hospital · Cardiovascular
No low molecular weight heparin works by inhibiting Factor Xa and thrombin.

Phase 3 pipeline (15)

Continuous heparin infusion · Yong Seog Oh · Cardiovascular
Heparin is an anticoagulant that inhibits multiple clotting factors to prevent thrombus formation.
Heparin, Low-Molecular-Weight · National and Kapodistrian University of Athens · Cardiovascular
Low-molecular-weight heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates clotting factors Xa and IIa.
Low Heparin Molecular Weight · University Hospital, Angers · Cardiovascular
Low molecular weight heparin (LMWH) inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates clotting factors Xa and IIa.
Heparin - Therapeutic dosage · University of Sao Paulo · Cardiovascular
Heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors.
Unfractioned heparin · Universidad de Antioquia · Cardiovascular
Unfractionated heparin works by activating antithrombin, a protein that inhibits the coagulation cascade.
Prevention of Venous Thromboembolism · Prof. Stavros Konstantinides, MD · Cardiovascular
This drug prevents the formation of blood clots in the veins by inhibiting the coagulation cascade.
Plasma-derived antithrombin · Kyowa Kirin Co., Ltd. · Cardiovascular
Plasma-derived antithrombin is a protein that inhibits the coagulation cascade by binding to and neutralizing thrombin and other coagulation factors.
Therapeutic Anticoagulation · Unity Health Toronto · Cardiovascular
Therapeutic anticoagulation involves the inhibition of blood clot formation to prevent thrombotic events.
low molecular weight heparin, 5-FU · Shahid Beheshti University of Medical Sciences · Cardiovascular
Low molecular weight heparin works by inhibiting Factor Xa and thrombin, preventing blood clot formation.
Heparin - Prophylactic dosage · University of Sao Paulo · Cardiovascular
Heparin inhibits blood coagulation by potentiating antithrombin III, which inactivates thrombin and other clotting factors to prevent clot formation.
Conventional low dose thromboprophylaxis · UMC Utrecht · Cardiovascular
Conventional low-dose thromboprophylaxis prevents blood clot formation by inhibiting coagulation cascade factors, typically using anticoagulants at reduced doses for prevention rather than treatment.
(LMW)heparin · Sanofi · Cardiovascular
Low-molecular-weight heparin inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates clotting factors Xa and IIa.
UFH (unfractionated heparin) · Assistance Publique - Hôpitaux de Paris · Cardiovascular
UFH inhibits blood coagulation by enhancing the activity of antithrombin III, which inactivates thrombin and other clotting factors.
Intermittent heparin infusion · Yong Seog Oh · Cardiovascular
Intermittent heparin infusion prevents blood clot formation by inhibiting thrombin and other coagulation factors through periodic intravenous administration.
sham mPENTOCLO · Sunnybrook Health Sciences Centre · Cardiovascular
Pentosan polysulfate sodium is an anticoagulant that works by inhibiting the coagulation cascade.

Phase 2 pipeline (3)

Du-Cotecxin · London School of Hygiene and Tropical Medicine · Cardiovascular
Du-Cotecxin is a heparin-based anticoagulant.
Enoxaparin Sodium Injection; Rivaroxaban Tablets · Beijing Suncadia Pharmaceuticals Co., Ltd · Cardiovascular
Enoxaparin sodium injection works by inhibiting Factor Xa and Factor IIa, preventing blood clot formation, while rivaroxaban tablets inhibit Factor Xa directly.
Anticoagulation treatment. · Samsung Medical Center · Cardiovascular
Anticoagulation via inhibition of vitamin K-dependent clotting factors